title: Paradoxical growth of Candida albicans in the presence of caspofungin is associated with multiple cell wall rearrangements and decreased virulence.
abstract: In the last decade, echinocandins have emerged as an important family of antifungal drugs because of their fungicidal activity against Candida spp. Echinocandins inhibit the enzyme β-1,3-d-glucan synthase, encoded by the FKS genes, and resistance to echinocandins is associated with mutations in this gene. In addition, echinocandin exposure can produce paradoxical growth, defined as the ability to grow at high antifungal concentrations but not at intermediate concentrations. In this work, we have demonstrated that paradoxical growth of Candida albicans in the presence of caspofungin is not due to antifungal degradation or instability. Media with high caspofungin concentrations recovered from wells where C. albicans showed paradoxical growth inhibited the growth of a Candida krusei reference strain. Cells exhibiting paradoxical growth at high caspofungin concentrations showed morphological changes such as enlarged size, abnormal septa, and absence of filamentation. Chitin content increased from the MIC to high caspofungin concentrations. Despite the high chitin levels, around 23% of cells died after treatment with caspofungin, indicating that chitin is required but not sufficient to protect the cells from the fungicidal effect of caspofungin. Moreover, we found that after paradoxical growth, β-1,3-glucan was exposed at the cell wall surface. Cells grown at high caspofungin concentrations had decreased virulence in the invertebrate host Galleria mellonella. Cells grown at high caspofungin concentrations also induced a proinflammatory response in murine macrophages compared to control cells. Our work highlights important aspects about fungal adaptation to caspofungin, and although this adaptation is associated with reduced virulence, the clinical implications remain to be elucidated.
authors.affiliation: Mycology Reference Laboratory, National Center for Microbiology, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.
authors.forename: Cristina
authors.initials: C
authors.lastname: Rueda
authors.forename: Manuel
authors.initials: M
authors.lastname: Cuenca-Estrella
authors.forename: Oscar
authors.initials: O
authors.lastname: Zaragoza
mesh_terms: D000818:Animals; D000935:Antifungal Agents / Q000494:pharmacology*; D002176:Candida albicans / Q000187:drug effects* / Q000378:metabolism / Q000472:pathogenicity / Q000648:ultrastructure; D000077336:Caspofungin; D002473:Cell Wall / Q000187:drug effects* / Q000648:ultrastructure; D002478:Cells, Cultured; D002686:Chitin / Q000037:antagonists & inhibitors / Q000096:biosynthesis; D017077:Culture Media, Conditioned / Q000494:pharmacology; D054714:Echinocandins / Q000494:pharmacology*; D007814:Larva / Q000382:microbiology; D055666:Lipopeptides; D008264:Macrophages / Q000276:immunology / Q000382:microbiology; D051379:Mice; D009036:Moths / Q000382:microbiology; D014774:Virulence; D047071:beta-Glucans / Q000378:metabolism
chemical_list: D000935:Antifungal Agents; D017077:Culture Media, Conditioned; D054714:Echinocandins; D055666:Lipopeptides; D047071:beta-Glucans; D002686:Chitin; C033363:beta-1,3-glucan; D000077336:Caspofungin